
China Ranks Second Globally in New Drug Development, NHC Reports
China emerges as a global leader in new drug development, with 20% of global research projects and breakthrough approvals in anti-cancer treatments.
News & Insights Across Asia
China emerges as a global leader in new drug development, with 20% of global research projects and breakthrough approvals in anti-cancer treatments.
Nagqu’s world-highest NICU and grassland restoration efforts showcase Xizang’s progress in healthcare and ecology at 4,500 meters.
China’s medical tech breakthroughs, including brain-computer interfaces and policy-driven R&D, are redefining global healthcare possibilities.
Former executive Cai Lei leads China’s fight against ALS through data-driven research and global collaboration, inspiring hope for patients worldwide.
Elon Musk’s Neuralink implants show promise in helping patients with paralysis, but face competition and ethical questions. Explore the latest developments in brain-computer interfaces.
On Global ALS Awareness Day, stories of resilience, AI breakthroughs, and global research efforts highlight the fight against this relentless disease.
China leverages AI technology to address its eye health challenges, marking the 30th National Sight Day with a focus on innovation and accessibility in vision care.
Peking Union Medical College Hospital collaborates with 156 institutions across five provinces to launch a tech-driven medical alliance, boosting rural healthcare access and resource sharing.
Hubei establishes China’s first pricing standards for brain-computer interface treatments, accelerating clinical adoption of neurotechnology across healthcare systems.
AstraZeneca CEO Pascal Soriot commends China’s unique governmental backing for businesses, emphasizing collaboration in healthcare and economic growth.
China releases BCI pricing guidelines, advancing clinical integration for paralysis treatment and neurotech innovation.
An NPC Deputy emphasizes the importance of strengthening AI infrastructure to enhance the Chinese mainland’s industry and healthcare sectors amid upcoming legislative sessions.